These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11533205)

  • 21. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
    Morales CE; Stieglitz E; Kogan SC; Loh ML; Braun BS
    Blood Adv; 2021 Sep; 5(18):3587-3591. PubMed ID: 34464969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.
    Wong JC; Zhang Y; Lieuw KH; Tran MT; Forgo E; Weinfurtner K; Alzamora P; Kogan SC; Akagi K; Wolff L; Le Beau MM; Killeen N; Shannon K
    Blood; 2010 Jun; 115(22):4524-32. PubMed ID: 20233966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation.
    Erkeland SJ; Valkhof M; Heijmans-Antonissen C; Delwel R; Valk PJ; Hermans MH; Touw IP
    Blood; 2003 Feb; 101(3):1111-7. PubMed ID: 12393438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
    Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
    Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
    Kim A; Morgan K; Hasz DE; Wiesner SM; Lauchle JO; Geurts JL; Diers MD; Le DT; Kogan SC; Parada LF; Shannon K; Largaespada DA
    Blood; 2007 Feb; 109(4):1687-91. PubMed ID: 17090653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.
    Bies J; Sramko M; Fares J; Rosu-Myles M; Zhang S; Koller R; Wolff L
    Blood; 2010 Aug; 116(6):979-87. PubMed ID: 20457873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.
    Balgobind BV; Van Vlierberghe P; van den Ouweland AM; Beverloo HB; Terlouw-Kromosoeto JN; van Wering ER; Reinhardt D; Horstmann M; Kaspers GJ; Pieters R; Zwaan CM; Van den Heuvel-Eibrink MM; Meijerink JP
    Blood; 2008 Apr; 111(8):4322-8. PubMed ID: 18172006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.
    Side LE; Emanuel PD; Taylor B; Franklin J; Thompson P; Castleberry RP; Shannon KM
    Blood; 1998 Jul; 92(1):267-72. PubMed ID: 9639526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup.
    Ramamoorthy S; Lebrecht D; Schanze D; Schanze I; Wieland I; Andrieux G; Metzger P; Hess M; Albert MH; Borkhardt A; Bresters D; Buechner J; Catala A; De Haas V; Dworzak M; Erlacher M; Hasle H; Jahnukainen K; Locatelli F; Masetti R; Stary J; Turkiewicz D; Vinci L; Wlodarski MW; Yoshimi A; Boerries M; Niemeyer CM; Zenker M; Flotho C
    Br J Haematol; 2024 Feb; 204(2):595-605. PubMed ID: 37945316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the NF1 gene in leukemogenesis and myeloid growth control.
    O'Marcaigh AS; Shannon KM
    J Pediatr Hematol Oncol; 1997; 19(6):551-4. PubMed ID: 9407945
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.
    Cho BC; Shaughnessy JD; Largaespada DA; Bedigian HG; Buchberg AM; Jenkins NA; Copeland NG
    J Virol; 1995 Nov; 69(11):7138-46. PubMed ID: 7474134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.
    Bies J; Nazarov V; Wolff L
    J Virol; 1999 Mar; 73(3):2038-44. PubMed ID: 9971784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages of the CBA mouse in leukemogenesis research.
    Rithidech KN; Cronkite EP; Bond VP
    Blood Cells Mol Dis; 1999 Feb; 25(1):38-45. PubMed ID: 10349512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M
    Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia.
    Erkeland SJ; Verhaak RG; Valk PJ; Delwel R; Löwenberg B; Touw IP
    Cancer Res; 2006 Jan; 66(2):622-6. PubMed ID: 16423987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited predispositions and hyperactive Ras in myeloid leukemogenesis.
    Lauchle JO; Braun BS; Loh ML; Shannon K
    Pediatr Blood Cancer; 2006 May; 46(5):579-85. PubMed ID: 16261595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent progress of study on retroviral mediated mouse model of myeloid leukemia --- review].
    Shi L; Wang YY; Chen SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1058-63. PubMed ID: 21867644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
    Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
    Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE; Humphries RK; Thomas TE; Hogge DE
    Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.